Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
ProBioGen to Lead GMP Manufacturing Operations at Berlin Center for Gene and Cell Therapies (BC GCT)
Wednesday, September 17, 2025ProBioGen and the Berlin Institute of Health at Charit BIH announced today that ProBioGen has been selected to operate the process development and good manufacturing practice GMP production
CPHI Frankfurt 2025 to welcome more than 60,000 pharma professionals as the global event returns to Germany
Wednesday, September 17, 2025Informa Markets will once again welcome the global pharmaceutical industry to CPHI Frankfurt running from October to at Messe Frankfurt The threeday event is expected to draw more than attendees
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Tuesday, September 16, 2025Novo Nordisk today announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has approved an update to the Rybelsus oral semaglutide label
Basilea receives USD 25 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
Tuesday, September 16, 2025Basilea Pharmaceutica Ltd Allschwil a commercialstage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections announced today that the Biomedical
Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
Friday, September 12, 2025Nacuity Pharmaceuticals Inc Nacuity a clinicalstage biopharmaceutical company focused on innovative treatment of ocular diseases involving oxidative stress today announced positive
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
Thursday, September 11, 2025CAMP Therapeutics Corporation Pa clinicalstage biopharmaceutical company developing a pipeline of regulatory RNAtargeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels
European Biopharma Sector Sees Major Investments in Biologic Therapies
Thursday, September 11, 2025The biopharmaceutical industry in Europe is witnessing a significant surge in investments aimed at developing biologic therapies
New Clinical Trial Framework Announced by European Medicines Agency
Thursday, September 11, 2025The European Medicines Agency has unveiled a new framework designed to streamline clinical trial processes across Europe
European Biopharmaceutical Leaders Unite to Enhance R&D Collaboration
Wednesday, September 10, 2025European biopharmaceutical companies are forming strategic partnerships to advance research and development efforts
New Advanced Pharmaceutical Manufacturing Facility Opens in Germany
Wednesday, September 10, 2025A stateoftheart pharmaceutical manufacturing facility has officially opened in Germany enhancing production capabilities
